Streetbeat News

Stock Prices

RXRX

Recursion (NASDAQ:RXRX) provided updated guidance on seven clinical trial readouts expected within the next 18 months and shared partnership updates, including a collaboration with Bayer on oncology projects and the use of Recursion's LOWE for drug discovery.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:07 pm

CRNC

VWAGY

Volkswagen Group has deployed Cerence Chat Pro, an AI-powered in-car assistant, to its European models. This marks the first time the solution is available to drivers, leveraging ChatGPT's large language model for enhanced conversational capabilities.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:04 pm

FDMT

4D Molecular Therapeutics (FDMT) announced that the FDA has cleared its IND application for 4D-175, a genetic medicine for treating geographic atrophy. The treatment uses a proprietary AAV vector and a codon-optimized transgene. Phase 1 clinical trial enrollment is expected to begin in H2 2024.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:04 pm

IFRX

InflaRx's GOHIBIC (Vilobelimab) has been selected by BARDA for a Phase 2 study on Acute Respiratory Distress Syndrome. The DSMB has recommended continuation without modification for the third time, with a safety review including 395 patients. An interim survival analysis is expected early 2025, and rapid enrollment positions the company for completion by Q1 2025.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:04 pm

CRVO

CervoMed Inc. (NASDAQ:CRVO) will be added to the Russell 2000 and Russell 3000 Indexes effective July 1, 2024, as part of the annual reconstitution of the Russell U.S. Indexes.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:03 pm

EOSE

Eos Energy Enterprises has announced a strategic investment of up to $315.5 million from Cerberus Capital Management. This investment aims to enhance Eos' operating capabilities and strengthen its position in the global energy market.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:02 pm

SEVN

Seven Hills Realty Trust (SEVN) will be added to the Russell 3000 Index after the market close on June 28, 2024.

Portfolio Pulse from Benzinga Newsdesk

June 24, 2024 | 12:02 pm

AMC

DJT

GME

META

Trump Media & Technology Group Corp (NASDAQ:DJT) is trading higher after announcing it expects to receive over $69.4 million from the cash exercise of warrants in June 2024. The company could receive up to $247 million if all warrants are exercised. Despite a significant decline in market value, TMTG plans to use the funds for platform development and potential mergers and acquisitions.

Portfolio Pulse from Anusuya Lahiri

June 24, 2024 | 12:01 pm

IBM

IBM (NYSE:IBM) has been analyzed by 13 analysts over the past three months, revealing a mix of bullish and bearish sentiments. The average 12-month price target is $182.23, with a high of $210.00 and a low of $130.00. Recent analyst actions include both upgrades and downgrades, reflecting varied perspectives on IBM's future performance.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 12:01 pm

HALO

Over the past three months, 12 analysts have evaluated Halozyme Therapeutics (NASDAQ:HALO), with the majority being bullish. The average 12-month price target has increased to $55.0. Key financial indicators show strong profitability and efficient use of assets, but the company carries substantial debt.

Portfolio Pulse from Benzinga Insights

June 24, 2024 | 12:01 pm